Companies: 10,795·Total market cap: $144.5T
Wave Life Sciences Ltd.

Wave Life Sciences Ltd.

WVENASDAQHealthcare● Active
$5.80
+$0.07(+1.15%)
Market Cap$1.1B
P/E Ratio
52W High$21.73
52W Low$5.02
Overview

Wave Life Sciences Ltd.(WVE)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · WVE · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$42.73M$108.30M$113.31M$3.65M$40.96M
Cost of Revenue$8.85M$0.00M$0.00M$0.00M$0.00M
Gross Profit$33.88M$108.30M$113.31M$3.65M$40.96M
Gross Margin %(computed)79.28%100.00%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$182.78M$159.68M$130.01M$115.86M$121.88M
G&A Expenses$75.33M$59.02M$51.29M$50.51M$46.10M
Total Operating Expenses$249.26M$218.71M$181.30M$166.37M$167.98M
Operating Income($215.38M)($110.40M)($68.00M)($162.72M)($127.02M)
Operating Margin %(computed)-504.09%-101.94%-60.01%-310.07%
Interest Income$10.48M$0.00M$0.00M$0.00M$0.03M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($204.38M)($97.01M)($58.19M)($161.14M)($122.45M)
Income Tax Expense$0.00M$0.00M($0.68M)$0.68M($0.20M)
Net Income($204.38M)($97.01M)($57.51M)($161.82M)($122.25M)
Net Margin %(computed)-478.33%-89.57%-50.76%-298.42%
Per Share & EBITDA
EPS (Basic)$-1.21$-0.70$-0.54$-2.05$-2.36
Wtd Avg Shares168.65M138.28M106.10M78.86M51.83M
EBITDA($195.53M)($101.74M)($58.79M)($152.61M)($117.18M)
EBITDA Margin %(computed)-457.62%-93.94%-51.89%-286.06%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Wave Life Sciences Ltd.

关于Wave Life Sciences Ltd.(WVE)损益表

Wave Life Sciences Ltd.(WVE)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,WVE实现营收$0.04B,毛利润$0.03B(毛利率79.28%),净利润($0.20B)(净利率-478.33%)。

常见问题

WVE · 4 问

Wave Life Sciences Ltd.(WVE)2025财年营收为$0.04B,同比down60.5%。

WVE revenueWVE salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08